Insider Trading History of Garrity Thomas J

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Garrity Thomas J since 2011. This trader's CIK number is 1275012. At the time of last reporting, Garrity Thomas J was the Director of Antares Pharma, Inc.. (stock ticker symbol ATRS). Also see all insider trading activities at Antares Pharma, Inc..


Yearly summary of insider trading at Antares Pharma, Inc. (ATRS) by Garrity Thomas J

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 ATRS 0 $0 170,000 $729,200 170,000 $229,600
2019 ATRS 0 $0 110,000 $446,460 120,000 $157,299
2017 ATRS 0 $0 60,000 $192,270 60,000 $75,000
2016 ATRS 30,000 $21,600 0 $0 0 $0
2014 ATRS 5,000 $9,900 0 $0 0 $0
2013 ATRS 0 $0 13,000 $53,001 0 $0
2012 ATRS 0 $0 31,000 $124,464 90,750 $106,927
2011 ATRS 10,000 $15,943 0 $0 0 $0


Insider trading of Antares Pharma, Inc. (ATRS) by Garrity Thomas J

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-03-11 ATRS Option Ex 50,000 1.12 56,000
2021-03-11 ATRS Sale 50,000 4.28 214,000
2021-02-11 ATRS Option Ex 50,000 1.12 56,000
2021-02-11 ATRS Sale 50,000 4.62 231,000
2021-01-11 ATRS Sale 70,000 4.06 284,200
2021-01-11 ATRS Option Ex 70,000 1.68 117,600
2019-12-09 ATRS Sale 80,000 4.58 366,480
2019-12-09 ATRS Option Ex 80,000 1.63 130,399
2019-11-01 ATRS Option Ex 10,000 1.10 11,000
2019-05-01 ATRS Option Ex 30,000 .53 15,900
2019-05-01 ATRS Sale 30,000 2.67 79,980
2017-10-03 ATRS Option Ex 30,000 .85 25,500
2017-10-03 ATRS Sale 30,000 3.50 105,000
2017-03-31 ATRS Sale 30,000 2.91 87,270
2017-03-31 ATRS Option Ex 30,000 1.65 49,500
2016-03-18 ATRS Buy 30,000 .72 21,600
2014-08-11 ATRS Buy 5,000 1.98 9,900
2013-05-31 ATRS Sale 13,000 4.08 53,001
2012-08-20 ATRS Option Ex 32,250 1.26 40,764
2012-08-20 ATRS Option Ex 58,500 1.13 66,163
2012-08-20 ATRS Sale 31,000 4.01 124,464
2011-03-18 AIS Buy 7,000 1.58 11,053
2011-03-21 AIS Buy 3,000 1.63 4,890

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Garrity Thomas J (Director of Antares Pharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.